Breaking News

You are here » Indian-Commodity  :  Corporate  :  Bharti Airtel conducting trials of VoLTE technology in five circles

11-Jul2017

Bharti Airtel conducting trials of VoLTE technology in five circles

India's largest mobile operator Bharti Airtel is conducting trials of Voice over Long-Term Evolution (VoLTE) or voice over LTE technology in five cities, and hopes to take it pan-India in the later part of the year. VoLTE is a technology for facilitating voice on 4G network, and lowers the cost of offering voice calls.

The rollout of VoLTE by larger players like Airtel is expected to open up a new frontier in the price war with its competitor Reliance Jio.

Bharti Airtel is a leading integrated telecommunications company with operations across Asia and Africa. The company ranks amongst the top 3 mobile service providers globally in terms of subscribers.


Related News

View all news

RPP Infra Projects bags orders worth Rs 62.90 crore from BHEL

RPP Infra Projects has bagged orders from Bharat Heavy Electricals (BHEL), Chennai for worth of Rs 62.90 crore. The first order is for providing civil works of Boiler, Mill and Bunker, ESP area of unit......

Glenmark gets tentative ANDA approval for Abiraterone Acetate Tablets

Glenmark Pharmaceuticals Inc., USA (Glenmark) has been granted tentative approval by the United States Food & Drug Administration (USFDA) for Abiraterone Acetate Tablets USP, 250 mg, a generic......

HDFC Standard Life Insurance reports 18% rise in Q3 net profit

HDFC Standard Life Insurance has reported results for third quarter ended December 31, 2018. The company has reported a rise of 18.48% in its net profit at Rs 245.63 crore for the quarter under review......

Top News

View all news

RPP Infra Projects bags orders worth Rs 62.90 crore from BHEL

RPP Infra Projects has bagged orders from Bharat Heavy Electricals (BHEL), Chennai for worth of Rs 62.90 crore. The first order is for providing civil works of Boiler, Mill and Bunker, ESP area of unit......

Glenmark gets tentative ANDA approval for Abiraterone Acetate Tablets

Glenmark Pharmaceuticals Inc., USA (Glenmark) has been granted tentative approval by the United States Food & Drug Administration (USFDA) for Abiraterone Acetate Tablets USP, 250 mg, a generic......

HDFC Standard Life Insurance reports 18% rise in Q3 net profit

HDFC Standard Life Insurance has reported results for third quarter ended December 31, 2018. The company has reported a rise of 18.48% in its net profit at Rs 245.63 crore for the quarter under review......